Added to YB: 2026-08-14
Pitch date: 2026-08-11
AQST [bullish]
Aquestive Therapeutics, Inc.
-0.47%
current return
Author Info
No bio for this author
Company Info
Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally.
Market Cap
$530.9M
Pitch Price
$4.27
Price Target
6.50 (+53%)
Dividend
N/A
EV/EBITDA
-9.77
P/E
-6.50
EV/Sales
9.09
Sector
Pharmaceuticals
Category
special_situation
I'm up 20% in 2 weeks on this unknown pharma stock: The best is yet to come (50% upside) - $AQST
AQST: Epinephrine oral film (Anaphylm) rejected by FDA Jan 2026 only on packaging/human-factors, no efficacy/safety/mfg issues. Aug redesign cut pouch-open to 3s, placement errors -80%. Analysis of 21 similar rejections: single-fix cases approved in ~14mo. Author sees 80% approval odds, ~$6.50 by spring 2027 vs $4.29 now (50% priced in); $2.25 downside floor. $540M cap.
Read full article (10 min)